One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.

Exclusive Supply Agreement: A contractual arrangement where UFP Technologies ( UFPT 2.21%) is the sole supplier of specified ...

A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.

Zisapel explained that the current demand environment is "solid" and not meaningfully changed from the prior quarter, while ...

Acquisition Announcement -- VSE Corporation ( VSEC 0.75%) signed a definitive agreement to acquire Aero 3 for $350 million in ...

Both of these electric air taxi pioneers have sold off hard recently, creating a potential entry point for patient investors.

Upcoming product launches -- AMP-007 inhalation on track for mid-2026 launch targeting a $1.5 billion market; generic ...

BradyScan App Launch -- Announced as available on Android and Apple, supporting barcode generation, scanning, security ...

Net Income -- $7.6 million, down from $9.3 million. Net income attributable to Karat ( KRT +1.51%) was $7.3 million, or $0.36 ...

gTLD process -- The ICANN 2026 round of new generic Top-Level Domains is intended to start in Q2 2026, with no future ...

Recognition -- The company achieved a ranking of 74th in Time Magazine's America's Growth Leaders 2026 list, among over 4,000 ...

Join us as we dissect Lululemon's stock performance and explore whether it can reclaim its former glory in the competitive ...